MENU
SPRO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Spero Therapeutics (SPRO) Earnings Date & Reports

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm... Show more

A.I. Advisor
published Earnings

SPRO is expected to report earnings to rise 69.23% to -21 cents per share on March 26

Spero Therapeutics SPRO Stock Earnings Reports
Q4'25
Est.
$-0.22
Q3'25
Beat
by $0.26
Q2'25
Beat
by $0.54
Q1'25
Beat
by $0.02
Q4'24
Missed
by $0.02
The last earnings report on November 13 showed earnings per share of -12 cents, beating the estimate of -38 cents. With 171.81K shares outstanding, the current market capitalization sits at 130.14M.
View a ticker or compare two or three
SPRO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SPRO showed earnings on November 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of novel therapies for the treatment of resistant bacterial infections

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
675 Massachusetts Avenue
Phone
+1 857 242-1600
Employees
46
Web
https://www.sperotherapeutics.com